Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Smith & Nephew Snats ADR (NY: SNN )

25.90 +0.12 (+0.47%)
Official Closing Price Updated: 7:00 PM EDT, Jun 12, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 604,226
Open 26.04
Bid (Size) 25.38 (1)
Ask (Size) 26.59 (1)
Prev. Close 25.78
Today's Range 25.90 - 26.14
52wk Range 21.52 - 32.28
Shares Outstanding N/A
Dividend Yield 3.57%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Smith+Nephew personalizes robotic-assisted surgery for patients and surgeons with launch of CORIOGRAPH™ Pre-Operative Planning and Modeling Services exclusively for the CORI™ Surgical System
From Smith & Nephew UK Ltd
Via GlobeNewswire
4 Stocks to Watch in the Booming Regenerative Medicine Market
Regenerative medicine is revolutionizing healthcare. It encompasses a range of cutting-edge therapies aimed at repairing or replacing damaged tissues and organs, offering tangible solutions rather than... 
Via TheNewswire.com

Performance

YTD
-3.54%
-3.54%
1 Month
+3.15%
+3.15%
3 Month
-6.90%
-6.90%
6 Month
-3.25%
-3.25%
1 Year
-13.41%
-13.41%

More News

Read More
4 Stocks to Watch in the Booming Regenerative Medicine Market
Via News Direct
Current Analysis: Smith & Nephew
Via Talk Markets
Earnings Scheduled For August 3, 2023
Via Benzinga
Smith+Nephew announces new evidence supporting ALLEVYN LIFE Foam Dressing’s role in pressure injury prevention
From Smith & Nephew UK Ltd
Via GlobeNewswire
Smith+Nephew’s PICO™ Single Use Negative Pressure Wound Therapy System provides better clinical outcomes versus standard of care according to UK National Institute for Health and Care Excellence (NICE)
From Smith & Nephew UK Ltd
Via GlobeNewswire
Smith+Nephew introduces the RENASYS™ EDGE Negative Pressure Wound Therapy System – an exciting new option in home-based care for patients living with chronic wounds
From Smith & Nephew UK Ltd
Via GlobeNewswire
Smith+Nephew teams up with UFC to be first-ever Preferred Sports Medicine Technology Partner
From Smith & Nephew UK Ltd
Via GlobeNewswire
7 Robotic Surgery Stocks to Buy for the Future of Healthcare
Via InvestorPlace
British MedTech Firm Smith & Nephew Seeks To Adopt US-Inspired Pay Policy to Navigate Shareholder Skepticism
Via Benzinga
Smith+Nephew and U.S. Army Institute of Surgical Research to engage in Master Cooperative Research and Development Agreement
From Smith & Nephew UK Ltd
Via GlobeNewswire
3 Millionaire-Maker Robotics Stocks to Buy in February 2024
Via InvestorPlace
Smith+Nephew announces commercial launch of its AETOS™ Shoulder System for anatomic and reverse shoulder replacement at AAOS 2024 Annual Meeting
From Smith & Nephew UK Ltd
Via GlobeNewswire
Smith+Nephew to showcase leading, innovative AI-driven robotic-assisted solutions for personalized orthopaedic surgery at AAOS 2024 Annual Meeting
From Smith & Nephew UK Ltd
Via GlobeNewswire
Smith+Nephew unveils expanded Sports Medicine portfolio to enable biological healing at AAOS 2024 Annual Meeting
From Smith & Nephew UK Ltd
Via GlobeNewswire
New study confirms Smith+Nephew’s REGENETEN™ Bioinductive Implant reduces full-thickness rotator cuff re-tear rates¹ by 68%
From Smith & Nephew UK Ltd
Via GlobeNewswire
Santa Rally comes early for these stocks
Via MarketBeat
Alphabet To Rally Over 10%? Here Are 10 Other Analyst Forecasts For Wednesday
Via Benzinga
Smith & Nephew Raises Revenue Growth Outlook After Strong 1H Performance, Sports Medicine and Wound Management Show Strength
Via Benzinga
AstraZeneca, ECARX Holdings And Other Big Stocks Moving Lower On Monday
Via Benzinga
Amgen Out, Rio Tinto In As Morgan Stanley Shuffles Dividend Deck
Via Benzinga
Boeing, CyberArk Lead 5 Stocks Near Buy Points
Via Investor's Business Daily
Surgical Centers, Med-Tech Stocks Up On Pent-Up Surgical Demand
Via MarketBeat
UnitedHealth's Bad News Hits Insurers, But Surgery Partners Signals Breakout
Via Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.